Human regulatory T cells and autoimmunity

European Journal of Immunology

Volumn 38, Issue 4, 2008, Pages 921-924

  Cosantino, Cristina M ^a   Baecher Allan, Clare M ^a   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Autoimmunity; Human; Regulatory T cell

Indexed keywords

CD45RA ANTIGEN; CD45RB ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR FOXP3; HLA ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; CELL MEMBRANE; IMMUNOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL MEMBRANE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 44849089131     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200738104     Document Type: Note

References (29)

1. Lamb, J. R. et al., J. Exp. Med. 1983 157: 1434-1447.
2. Dorf, M. E. and Benacerraf, B., Annu. Rev. Immunol. 1984 2: 127-157.
3. Holling, T. M. et al., J. Immunol. 2002 168: 763-770.
4. Ko, H. S. et al., J. Exp. Med. 1979 150: 246-255.
5. Evans, R. L. et al., J. Exp. Med. 1978 148: 1440-1445.
6. Yu, D. T. et al., J. Exp. Med. 1980 151: 91-100.
7. Lanzavecchia, A. et al., Nature 1988 334: 530-532.
8. Zinkernagel, R. M. et al., Immunol. Cell. Biol. 2004 82: 343-352.
9. Baecher-Allan, C. et al., J. Immunol. 2001 167: 1245-1253.
10. Dieckmann, D. et al., J. Exp. Med. 2001 193: 1303-1310.
11. Wang, J. et al., Eur. J. Immunol. 2007 37: 129-138.
12. Fontenot, J. D. et al., Immunity 2005 22: 329-341.
13. Liu, W. et al., J. Exp. Med. 2006 203: 1701-1711.
14. Seddiki, N. et al., J. Exp. Med. 2006 203: 1693-1700.
15. Ruprecht, C. R. et al., J. Exp. Med. 2005 201: 1793-1803.
16. Baecher-Allan, C. et al., J. Immunol. 2006 176: 4622-4631.
17. Baecher-Allan, C. et al., Immunol. Rev. 2006 212: 203-216.
18. Dieckmann, D. et al., J. Exp. Med. 2002 196: 247-253.
19. Jonuleit, H. et al., J. Exp. Med. 2002 196: 255-260.
20. Baecher-Allan, C. et al., J. Immunol. 2002 169: 6210-6217.
21. Scholz, C. et al., J. Immunol. 1998 160: 1532-1538.
22. Cao, D. et al., Eur. J. Immunol. 2003 33: 215-223.
23. Vijlietta, V. et al., J. Exp. Med. 2004 199: 971-979.
24. Sugiyama, H. et al., J. Immunol. 2005 174: 164-173.
25. Lindley, S. et al., Diabetes 2005 54: 92-99.
26. Balandina, A. et al., Ann. NY Acad. Sci. 2003 998: 275-277
27. Gambineri, E. et al., Curr. Opin. Rheumatol. 2003 15: 430-435.
28. Hafler, D. A. et al., N. Engl. J. Med. 2007 357: 851-862.
29. The Wellcome Trust Case Consortium. Nature 2007 447: 661-678.